Skip to content
Screener

G&A at other companies

Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$11.46M+24.6%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$24.39M+53.1%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$13.12M+41.4%
CalAmp logo
CalAmpCAMP
$4.21M+10.3%
Biohaven logo
BiohavenBHVN
$26.6M-21.7%
Wave Life Sciences logo
Wave Life SciencesWVE
$24.78M+37.8%

Other financials

Income statement

See full
Revenue-
Operating income-$108.9M+2.9%
Net income-$109.9M+0.1%
EPS (diluted)-$0.84+14.3%

Balance sheet

See full
Cash & equivalents$437.1M+186%
Total debt$203.8M+231%
Total equity$253.8M+8.8%
Total assets$523.5M+54.0%

Cash flow

See full
Operating cash flow-$70.3M+8.6%
CapEx$1.0K-99.5%
Free cash flow-$70.3M+8.9%

Valuation

See full
Market cap$6.41B+92.7%
Enterprise value$6.18B+90.9%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-167.8%-4.1pp
Debt / equity0.8×+0.5×
Current ratio+0.7×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The source filing: Scholar Rock’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:20 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336732
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Operating expenses:
Research and development$$58,23462,401$110,048$111,079
General and administrative50,66749,708100,86978,120
Total operating expenses108,901112,109210,917189,199
Loss from operations(108,901)(112,109)(210,917)(189,199)
Other income (expense):
Loss on extinguishment of debt(3,337)
Interest income4,0933,4117,0287,641

Item 1. Financial Statements

FAQ

What is Scholar Rock's G&A?
Scholar Rock (SRRK) reported G&A of $50.67M in Q2 2026.
How has Scholar Rock's G&A changed year-over-year?
Scholar Rock's G&A increased by 1.9% year-over-year, from $49.71M to $50.67M.
What is the long-term trend for Scholar Rock's G&A?
Over 4 years (2021 to 2025), Scholar Rock's G&A has grown at a 44.6% compound annual growth rate (CAGR), from $40.27M to $176.21M.
What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Ask your AI about Scholar Rock's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude